Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Padcev
Pharma
Astellas-Seagen, Eisai-Merck, BeiGene—Fierce Pharma Asia
ESMO congress 2022 features Padcev-Keytruda combo data in bladder cancer and liver cancer data from PD-1 inhibitors.
Angus Liu
Sep 9, 2022 10:09am
ESMO: Seagen's Padcev with Keytruda make case for bladder nod
Sep 7, 2022 6:05pm
ESMO preview: What to expect from Keytruda-Padcev combo?
Sep 7, 2022 10:36am
Merck-Seagen merger stalled over price: Bloomberg
Aug 26, 2022 9:45am
Seagen's Padcev, Merck's Keytruda shine as bladder cancer combo
Jul 26, 2022 12:01pm
Merck's possible Seagen buy won't happen before Q2 report: WSJ
Jul 19, 2022 8:00am
